Details of Drug-Drug Interaction
| Drug General Information (ID: DDI1AB46HR) | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Drug Name | Etidronic acid | Drug Info | Magnesium citrate | Drug Info | |||||
| Drug Type | Small molecule | Small molecule | |||||||
| Therapeutic Class | Bone Density Conservation Agents | Minerals And Electrolytes | |||||||
| Structure | |||||||||
| Mechanism of Etidronic acid-Magnesium citrate Interaction (Severity Level: Moderate) | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Complex formation Click to Show/Hide Mechanism Graph | |||||||||
![]() |
|||||||||
| Drug Name | Etidronic acid | Magnesium citrate | |||||||
| Mechanism | Binds to polyvalent cations | Polyvalent cations | |||||||
| Key Mechanism Factor 1 | |||||||||
| Factor Name | Chelation | ||||||||
| Factor Description | Chelation is a direct drug interaction that usually involves the formation of dimers or trimers, resulting in larger complexes and poorer absorption. | ||||||||
| Mechanism Description |
|
||||||||
| Recommended Action | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Management | Antacids or other oral medications containing aluminum, calcium, magnesium and other polyvalent cations should be administered at least 2 hours before or 2 hours after the bisphosphonate dose. | ||||||||

